| MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib J Bean, C Brennan, JY Shih, G Riely, A Viale, L Wang, D Chitale, N Motoi, ... Proceedings of the National Academy of Sciences 104 (52), 20932-20937, 2007 | 1990 | 2007 |
| Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer YL Wu, M Tsuboi, J He, T John, C Grohe, M Majem, JW Goldman, ... New England Journal of Medicine 383 (18), 1711-1723, 2020 | 1635 | 2020 |
| First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study JC Soria, DSW Tan, R Chiari, YL Wu, L Paz-Ares, J Wolf, SL Geater, ... The Lancet 389 (10072), 917-929, 2017 | 1280 | 2017 |
| Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3 … JCH Yang, LV Sequist, SL Geater, CM Tsai, TSK Mok, M Schuler, ... The lancet oncology 16 (7), 830-838, 2015 | 1037 | 2015 |
| MicroRNA signature predicts survival and relapse in lung cancer SL Yu, HY Chen, GC Chang, CY Chen, HW Chen, S Singh, CL Cheng, ... Cancer cell 13 (1), 48-57, 2008 | 990 | 2008 |
| Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. PC Yang, KT Luh, DB Chang, HD Wu, CJ Yu, SH Kuo AJR. American journal of roentgenology 159 (1), 29-33, 1992 | 698 | 1992 |
| Mycobacterium abscessus complex infections in humans MR Lee, WH Sheng, CC Hung, CJ Yu, LN Lee, PR Hsueh Emerging infectious diseases 21 (9), 1638, 2015 | 592 | 2015 |
| Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line … T Mok, YL Wu, JS Lee, CJ Yu, V Sriuranpong, J Sandoval-Tan, G Ladrera, ... Clinical Cancer Research 21 (14), 3196-3203, 2015 | 544 | 2015 |
| Effectiveness of tyrosine kinase inhibitors on “uncommon” epidermal growth factor receptor mutations of unknown clinical significance in non–small cell lung cancer JY Wu, CJ Yu, YC Chang, CH Yang, JY Shih, PC Yang Clinical cancer research 17 (11), 3812-3821, 2011 | 507 | 2011 |
| Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan PR Hsueh, LJ Teng, CY Chen, WH Chen, SW Ho, KT Luh Emerging infectious diseases 8 (8), 827, 2002 | 470 | 2002 |
| Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells YC Liu, HY Yen, CY Chen, CH Chen, PF Cheng, YH Juan, CH Chen, ... Proceedings of the National Academy of Sciences 108 (28), 11332-11337, 2011 | 437 | 2011 |
| Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis JY Chien, JS Jerng, CJ Yu, PC Yang Critical care medicine 33 (8), 1688-1693, 2005 | 437 | 2005 |
| Pulmonary Sequelae in Convalescent Patients after Severe Acute Respiratory Syndrome: Evaluation with Thin-Section CT1 YC Chang, CJ Yu, SC Chang, JR Galvin, HM Liu, CH Hsiao, PH Kuo, ... Radiology 236 (3), 1067-1075, 2005 | 412 | 2005 |
| Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial YL Wu, JS Lee, S Thongprasert, CJ Yu, L Zhang, G Ladrera, ... The lancet oncology 14 (8), 777-786, 2013 | 405 | 2013 |
| Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response JY Wu, SG Wu, CH Yang, CH Gow, YL Chang, CJ Yu, JY Shih, PC Yang Clinical Cancer Research 14 (15), 4877-4882, 2008 | 367 | 2008 |
| Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Q Lan, CA Hsiung, K Matsuo, YC Hong, A Seow, Z Wang, HD Hosgood III, ... Nature genetics 44 (12), 1330-1335, 2012 | 348 | 2012 |
| Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome JY CHIEN, PR HSUEH, WC CHENG, CJ YU, PC YANG Respirology 11 (6), 715-722, 2006 | 311 | 2006 |
| Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line … CH Yang, CJ Yu, JY Shih, YC Chang, FC Hu, MC Tsai, KY Chen, ZZ Lin, ... Journal of Clinical Oncology 26 (16), 2745-2753, 2008 | 303 | 2008 |
| Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma JY Shih, MF Tsai, TH Chang, YL Chang, A Yuan, CJ Yu, SB Lin, GY Liou, ... Clinical cancer research 11 (22), 8070-8078, 2005 | 289 | 2005 |
| Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non–small-cell lung cancer TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen, L Zhang, J Ignacio, M Liao, ... Journal of Clinical Oncology 27 (30), 5080-5087, 2009 | 283 | 2009 |
